BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29909719)

  • 1. Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis.
    Dolan SB; Shetty RA; Forster MJ; Gatch MB
    J Psychopharmacol; 2018 Jul; 32(7):802-810. PubMed ID: 29909719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.
    Gatch MB; Dolan SB; Forster MJ
    Drug Alcohol Depend; 2019 Jun; 199():50-58. PubMed ID: 30986635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-Benzylpiperazine, Its Metabolite N-Benzylethylenediamine, and Its Disubstituted Analogue N,N'-Dibenzylpiperazine on the Acquisition, Formation, and Consolidation of Memory in Mice.
    Castillo-Hernández JC; Velázquez-Moyado JA; Reyes-Ramírez A; Ramírez-López EG; González-Andrade M; Navarrete A
    Pharmacology; 2017; 99(5-6):268-274. PubMed ID: 28219076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2016 Sep; 27(6):497-505. PubMed ID: 27028902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL; Katz EB; Coop A; Fantegrossi WE
    Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
    Fantegrossi WE; Winger G; Woods JH; Woolverton WL; Coop A
    Drug Alcohol Depend; 2005 Feb; 77(2):161-8. PubMed ID: 15664717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
    Dolan SB; Forster MJ; Gatch MB
    Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats.
    Gatch MB; Dolan SB; Forster MJ
    Psychopharmacology (Berl); 2017 Apr; 234(8):1237-1245. PubMed ID: 28210779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.
    Saber I; Milewski A; Reitz AB; Rawls SM; Walker EA
    Psychopharmacology (Berl); 2019 Mar; 236(3):1015-1029. PubMed ID: 30980094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of four novel synthetic cathinone analogs in rodents.
    Gatch MB; Shetty RA; Sumien N; Forster MJ
    Addict Biol; 2021 Jul; 26(4):e12987. PubMed ID: 33155384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse liability profile of three substituted tryptamines.
    Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
    J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ; Vorce SP; Holler JM; Lyons TP
    J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.
    Lee H; Wang GY; Curley LE; Kydd RR; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2869-77. PubMed ID: 27289365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro hepatotoxicity of 'Legal X': the combination of 1-benzylpiperazine (BZP) and 1-(m-trifluoromethylphenyl)piperazine (TFMPP) triggers oxidative stress, mitochondrial impairment and apoptosis.
    Dias da Silva D; Silva MJ; Moreira P; Martins MJ; Valente MJ; Carvalho F; Bastos ML; Carmo H
    Arch Toxicol; 2017 Mar; 91(3):1413-1430. PubMed ID: 27358233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzylpiperazine: a drug of abuse?
    Johnstone AC; Lea RA; Brennan KA; Schenk S; Kennedy MA; Fitzmaurice PS
    J Psychopharmacol; 2007 Nov; 21(8):888-94. PubMed ID: 17606471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants.
    Shetty RA; Hoch AC; Sumien N; Forster MJ; Gatch MB
    J Psychopharmacol; 2023 May; 37(5):520-528. PubMed ID: 36738095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic effects and their action mechanism of the major active components of party pill drugs.
    Min CR; Kim MJ; Park YJ; Kim HR; Lee SY; Chung KH; Oh SM
    Toxicol Lett; 2012 Nov; 214(3):339-47. PubMed ID: 23026265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.